Analytical Data
-
基因名
MYCL2
- Application
-
别名
MYCLP1; MYCL1P1; MYCL2; Putative myc-like protein MYCLP1; Protein L-Myc-2; V-myc myelocytomatosis viral oncogene homolog pseudogene 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P12525
-
表达区间
1-358 aa
-
氨基酸序列
MDRDSYHHYF YDYDGGEDFY RSTTPSEDIW KKFELVPPPW DLGPAAGNPA LSFGLLEPWP VGCAGDETES QDYWKAWDAN YASLIRRDCM WSGFSTQEPL ERAVSDLLAV GAPSGYSPKE FATPDYTPEL EAGNLAPIFP CLLGEPKIQA CSRSESPSDS EGEEIDVTVK KRQSLSTRKP VIIAVRADLL DPRMNLFHIS IHQQQHNYAA PFPPESCFQE GAPKRMPPKE ALEREAPGGK DDKEDEEIVS LPPVESEAAQ SCQPKPIHYD TENWTKKKYH SYLERKRRND QRSRFLALRD EVPALASCSR VSKVMILVKA TEYLHELAEA EERMATEKRQ LECQRRQLQK RIEYLSSY
-
分子量
40.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MYCL2, a member of the MYC family of transcription factors, plays a pivotal role in cell growth, differentiation, and apoptosis. Research has shown that MYCL2 is overexpressed in various cancers, making it a potential biomarker and therapeutic target. Its significance in oncogenic pathways has prompted scientists to investigate its functional mechanisms, including its role in gene regulation and interaction with other signaling pathways. Recombinant MYCL2 protein studies aim to elucidate the protein's structure-function relationship, provide insights into its role in tumorigenesis, and explore its potential in cancer therapy. The production of recombinant MYCL2 proteins allows researchers to perform detailed biochemical assays, structural analysis, and functional studies. These investigations can lead to a better understanding of MYCL2's contribution to malignancies and aid in the development of targeted therapies to inhibit its activity in cancer cells. The ongoing research into MYCL2 not only enhances our knowledge of cancer biology but also opens avenues for innovative treatment strategies aimed at improving patient outcomes.
